Irene Ghobrial, MD

Senior Vice President for Experimental Medicine / Director of the Center for Early Detection and Interception of Blood Cancers / Lavine Family Chair for Preventative Cancer Therapies / Director of the Ghobrial Lab at the Dana-Farber Cancer Institute

Dr. Ghobrial is the Senior Vice President for Experimental Medicine; Director of the Center for Early Detection and Interception of Blood Cancers; Lavine Family Chair for Preventative Cancer Therapies; and Director of the Ghobrial Lab at Dana-Farber Cancer Institute, as well as a Professor of Medicine at Harvard Medical School.

The focus of her research is early screening, identification of novel biomarkers of disease progression and the development of therapeutic interceptions in pre-malignant conditions. She leads translational studies to define genomic and immune mechanisms of disease progression from precursor myeloma as well as clinical trials to intercept disease progression.

Dr. Ghobrial earned her medical degree from Cairo University School of Medicine, Egypt. She completed her residency in Internal Medicine at Wayne State University, Michigan, and a Hematology/Oncology Fellowship at the Mayo Clinic College of Medicine, Minnesota, before joining Dana-Farber in 2004.